CITRUPRESS IV

Welcome to the Brand page for “CITRUPRESS IV”, which is offered here for Pharmaceuticals for the prevention of pulmonary hypertension in pediactric patients undergoing surgery for the correction of congenital heart defects;iv;.

Its status is currently believed to be active. Its class is unavailable. “CITRUPRESS IV” is believed to be currently owned by “Asklepion Pharmaceuticals, LLC”.

Owner:
ASKLEPION PHARMACEUTICALS, LLC
Owner Details
Description:
Pharmaceuticals for the prevention of pulmonary hypertension in pediactric patients undergoing surgery for the correction of congenital heart defects;IV;
Categories: PHARMACEUTICALS PREVENTION